-->

PBI-Gordon Acquires TriviumVet, Largest in Company History

PBI-Gordon Companies has acquired TriviumVet, expanding the company's portfolio in pet health. Photo credit: Shutterstock (SeventyFour).

Posted May 5, 2025

Shawnee-based PBI-Gordon Companies, Inc. announced its latest acquisition of TriviumVet, the newest acquisition in the company’s history.

The acquisition of TriviumVet is the largest transaction in the company’s 77-year history, according to a release Monday. TriviumVet is a veterinarian therapeutic solutions company headquartered in Waterford, Ireland.

The company is responsible for the drug products such as Felycin-CA1, the first U.S Food and Drug Administration conditionally approved drug for managing ventricular hypertrophy in cats. The drug will be available for veterinary customers in August, according to the release.

Pensacola, Florida-based Pegasus Laboratories Inc., the pharmaceutical company under PBI, is expected to hire 50 additional employees as a result of the acquisition.

“Driven by the powerful belief that the pets we love deserve the same advanced care and innovation as people, we came together with a common purpose, to create and deliver cutting-edge solutions to improve the quality of life for cats and dogs,” co-founder of TriviumVet, Louise Grubb said in the release. “By partnering with PBI-Gordon, we will be able to ensure that our innovative products and pipeline will have global reach that benefits pets and their owners around the world.”

Louise Grubb will remain on as Managing Director of TriviumVet, which will continue to work as an independent, yet integrated team in Waterford, Ireland as a fourth subsidiary of PBI Gordon Companies. The team will report to PBI-Gordon Companies’ Chief Operating Officer, Jackie Applegate.

“With TriviumVet, we have acquired a complete research and development organization with a complementary development philosophy that values precision, unmet need identification, and cross-functional collaboration between scientific, regulatory, and commercial teams,” CEO of PBI-Gordon, Stephen Clifford, said in the release. “Together we will drive innovation and deliver solutions that will shape a healthier future for pets and their owners worldwide.”

Founded in 1947, PBI-Gordon is entirely employee-owned. The company and its three subsidiaries develop, manufacture, and market products for the turf and ornamental Industries.